TY - JOUR
T1 - The adrenal peripheral clock
T2 - Glucocorticoid and the circadian timing system
AU - Son, Gi Hoon
AU - Chung, Sooyoung
AU - Kim, Kyungjin
N1 - Funding Information:
This work was supported by grants from the Korea Ministry of Education, Science and Technology (MEST) through the Brain Research Center for the 21st Century Frontier R&D Program in Neuroscience. Sooyoung Chung was supported by the Brain Korea 21 Research Fellowships from the MEST. Pacific Edit reviewed the manuscript prior to submission.
PY - 2011/10
Y1 - 2011/10
N2 - The mammalian circadian timing system is organized in a hierarchy, with the master clock residing in the suprachiasmatic nucleus (SCN) of the hypothalamus and subsidiary peripheral clocks in other brain regions as well as peripheral tissues. Since the local oscillators in most cells contain a similar molecular makeup to that in the central pacemaker, determining the role of the peripheral clocks in the regulation of rhythmic physiology and behavior is an important issue. Glucocorticoids (GCs) are a class of multi-functional adrenal steroid hormones, which exhibit a robust circadian rhythm, with a peak linked with the onset of the daily activity phase. It has long been believed that the production and secretion of GC is primarily governed through the hypothalamus-pituitary-adrenal (HPA) neuroendocrine axis in mammals. Growing evidence, however, strongly supports the notion that the periodicity of GC involves the integrated activity of multiple regulatory mechanisms related to circadian timing system along with the classical HPA neuroendocrine regulation. The adrenal-intrinsic oscillator as well as the central pacemaker plays a pivotal role in its rhythmicity. GC influences numerous biological processes, such as metabolic, cardiovascular, immune and even higher brain functions, and also acts as a resetting signal for the ubiquitous peripheral clocks, suggesting its importance in harmonizing circadian physiology and behavior. In this review, we will therefore focus on the recent advances in our understanding of the circadian regulation of adrenal GC and its functional relevance.
AB - The mammalian circadian timing system is organized in a hierarchy, with the master clock residing in the suprachiasmatic nucleus (SCN) of the hypothalamus and subsidiary peripheral clocks in other brain regions as well as peripheral tissues. Since the local oscillators in most cells contain a similar molecular makeup to that in the central pacemaker, determining the role of the peripheral clocks in the regulation of rhythmic physiology and behavior is an important issue. Glucocorticoids (GCs) are a class of multi-functional adrenal steroid hormones, which exhibit a robust circadian rhythm, with a peak linked with the onset of the daily activity phase. It has long been believed that the production and secretion of GC is primarily governed through the hypothalamus-pituitary-adrenal (HPA) neuroendocrine axis in mammals. Growing evidence, however, strongly supports the notion that the periodicity of GC involves the integrated activity of multiple regulatory mechanisms related to circadian timing system along with the classical HPA neuroendocrine regulation. The adrenal-intrinsic oscillator as well as the central pacemaker plays a pivotal role in its rhythmicity. GC influences numerous biological processes, such as metabolic, cardiovascular, immune and even higher brain functions, and also acts as a resetting signal for the ubiquitous peripheral clocks, suggesting its importance in harmonizing circadian physiology and behavior. In this review, we will therefore focus on the recent advances in our understanding of the circadian regulation of adrenal GC and its functional relevance.
KW - Adrenal gland
KW - Biological clock
KW - Circadian rhythm
KW - Glucocorticoid
KW - Hypothalamus-pituitary-adrenal (HPA) axis
KW - Steroidogenic acute regulatory protein (StAR)
UR - http://www.scopus.com/inward/record.url?scp=80053122726&partnerID=8YFLogxK
U2 - 10.1016/j.yfrne.2011.07.003
DO - 10.1016/j.yfrne.2011.07.003
M3 - Review article
C2 - 21802440
AN - SCOPUS:80053122726
SN - 0091-3022
VL - 32
SP - 451
EP - 465
JO - Frontiers in Neuroendocrinology
JF - Frontiers in Neuroendocrinology
IS - 4
ER -